UPM Institutional Repository

Vitamin D3-PEGylated hexosomes for gemcitabine and thymoquinone co-delivery: Unraveling the physicochemical characteristics, biocompatibility, and cytotoxicity against breast cancer cells


Citation

Loo, Yan Shan and Yusoh, Nur Aininie and Zahid, N. Idayu and Madheswaran, Thiagarajan and Ikeno, Shinya and Nurdin, Armania and Salim, Norazlinaliza and Lim, Hong Ngee and Mat Azmi, Intan Diana (2025) Vitamin D3-PEGylated hexosomes for gemcitabine and thymoquinone co-delivery: Unraveling the physicochemical characteristics, biocompatibility, and cytotoxicity against breast cancer cells. Journal of Drug Delivery Science and Technology, 114 (pt.A). art. no. 107445. pp. 1-16. ISSN 1773-2247

Abstract

An integration between co-delivery and the targeting ability of nanoparticles confers an important clinical implication in breast cancer treatment, as the progression, recurrence, and development of resistance towards standard therapy are associated with a crosstalk of aberrant signaling pathways. In this study, lipid-based nanoparticles structurally defined by the presence of an inverse hexagonal phase with aqueous channels within, i.e., hexosomes, were investigated for gemcitabine and thymoquinone (Gem-TQ) co-delivery and surface functionalization with vitamin D3-methoxypoly(ethylene glycol)2000 (VD-PEG). These hexosomes were prepared using soy phosphatidylcholine (SPC) and an emulsifier, citric acid esters of monoglycerides (citrem). VD-PEG/SPC/citrem/Gem-TQ hexosomes demonstrated mean hydrodynamic particle size of 336.5 ± 5.4 nm and entrapment efficiency of 97.7 ± 0.1 % (Gem) and 99.0 ± 0.1 % (TQ) at the compositional ratio of 2.5:2.5:0.1 wt% (SPC:citrem:VD-PEG) and co-loading at 2:9 μM Gem-TQ. Moreover, the half-maximal lethal dose (LD50) of VD-PEG/SPC/citrem/Gem-TQ determined in zebrafish (Danio rerio) embryos at Gem:TQ concentration of 4.6:20.8 μM was reduced by 1.3-fold compared to LD50 of Gem-TQ (non-encapsulated) solution. In addition, the inhibitory concentrations (IC50) following 24 h treatment using VD-PEG/SPC/citrem/Gem-TQ hexosomes were 33.4 ± 8.0 μM and 23.8 ± 2.9 μM against MCF7 and T-47D hormone receptor-positive luminal breast cancer cells, respectively. VD-PEG/SPC/citrem/Gem-TQ hexosomes containing methylene blue (MB) as the molecular fluorescent probe demonstrated higher cellular uptake in T-47D compared to MCF7 cells, therefore, the use of VD-PEG for the fabrication of lyotropic liquid crystalline nanoassemblies can be further investigated for its therapeutic potency and targeting mechanisms.


Download File

[img] Text
122437.pdf - Published Version
Restricted to Repository staff only

Download (7MB)

Additional Metadata

Item Type: Article
Subject: Pharmaceutical Science
Divisions: Faculty of Medicine and Health Science
Faculty of Science
Institute of Bioscience
Centre for Foundation Studies in Science of Universiti Putra Malaysia
DOI Number: https://doi.org/10.1016/j.jddst.2025.107445
Publisher: Editions de Sante
Keywords: Breast cancer; Citrem; Co-delivery; Hexosomes; Soy phosphatidylcholine; Surface functionalization
Depositing User: Ms. Zaimah Saiful Yazan
Date Deposited: 02 Mar 2026 07:53
Last Modified: 02 Mar 2026 07:53
Altmetrics: http://www.altmetric.com/details.php?domain=psasir.upm.edu.my&doi=10.1016/j.jddst.2025.107445
URI: http://psasir.upm.edu.my/id/eprint/122437
Statistic Details: View Download Statistic

Actions (login required)

View Item View Item